More focus required on hospice care for heart failure patientsNews-Medical.netBy Sarah Guy, medwireNews Reporter. End-stage heart failure patients enter hospice care closer to the time of their death, are more often referred from acute care facilities,…

Anthracycline, Trastuzumab for Breast CA Up Heart Failure RiskDoctors LoungeFor women with incident, invasive breast cancer, treatment with anthracycline and trastuzumab is associated with an increased risk of heart failure and/or cardiomyopathy, compa…

Medtronic study shows benefits of evidence-based heart failure therapyZenopaThe application of evidence-based performance improvement interventions in outpatient settings was shown to deliver equivalent improvements in the care of heart failure patient…

Heart failure drug approved by EUThorne GazetteSeveral other newspapers have reported on the drug ivabradine, known by the brand name Procoralan, as European drug regulators have today approved it for the treatment of chronic heart failure. In heart fa…

Global Acute Heart Failure (AHF) Therapeutics IndustrySacramento BeeThis report analyzes the worldwide markets for Acute Heart Failure (AHF) Therapeutics in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Eu…

Study evaluates prognostic utility of novel biomarkers of cardiovascular stressNews-Medical.netThe Framingham Heart Study Cohort evaluated over 3,400 individuals to determine the prognostic utility of ST2 individually, and when combined with other biom…

AlloCure commences AC607 Phase 2 clinical trial for acute kidney injuryNews-Medical.netAlloCure, Inc. today announced that it has initiated a phase 2 clinical trial of AC607, the company's mesenchymal stem cell therapy, as a potential treatment for…

NIAAA funds for Acetaminophen overdose-induced liver failure treatment studyPharmaceutical Business ReviewImproper use or overdose of Acetaminophen is said to cause severe liver damage with the potential to progress to APAP-induced liver injury (AILI) …

Study: Trastuzumab (Herceptin) Raises Risk of Heart FailureCancer NetworkAccording to a large population-based, retrospective study of 12,500 women treated for invasive breast cancer, treatment with trastuzumab (Herceptin) increases the risk of congest…

Revolutionary Biomarker Predicts Who Will Get Heart Disease Years in AdvanceThe Herald | HeraldOnline.comSAN DIEGO — Critical Diagnostics announced today, Circulation, an American Heart Association Journal, released online the first study evaluating …